NCT05845593View on ClinicalTrials.gov

Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE)

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 19, 2023

Primary Completion Date

December 10, 2024

Study Completion Date

March 5, 2025

Conditions
Lupus Erythematosus, Systemic
Interventions
OTHER

Decision Support Test

LuGENE®, a transcriptomic-based LDT, with standard evaluation of patients diagnosed with SLE

Trial Locations (11)

10021

NOT_YET_RECRUITING

The Hospital for Special Surgery, New York

11030

RECRUITING

Feinstein Institute for Medical Research, Manhasset

21201

NOT_YET_RECRUITING

University of Maryland School of Medicine, Baltimore

28207

RECRUITING

Arthritis and Osteoporosis Consultants of the Carolinas, Charlotte

44195

NOT_YET_RECRUITING

Cleveland Clinic, Cleveland

55096

NOT_YET_RECRUITING

Mayo Clinic, Rochester

60612

NOT_YET_RECRUITING

Rush University Medical Center, Chicago

85032

NOT_YET_RECRUITING

Arizona Arthritis & Rheumatology Research, PLLC, Phoenix

90048

RECRUITING

Cedars-Sinai Medical Center, Los Angeles

90404

NOT_YET_RECRUITING

Providence St. John's Health Center - Rheumatology, Santa Monica

06519

NOT_YET_RECRUITING

Yale School of Medicine, New Haven

All Listed Sponsors
lead

Ampel BioSolutions, LLC

INDUSTRY